The Scientific and Ethics Advisory Board (SEAB) support the Governing Board, and are consulted on the progress of the B1MG project.
The SEAB consists of international experts not directly involved in the B1MG project. They meet once a year face-to-face at the General Assembly, and virtually when required. The B1MG consortium may incorporate additional experts, to ensure the delivery of project objectives, but any proposal need to be approved by the Governing Board.
- Anne Cambon-Thomsen (Emeritus Research Director at CNRS, Director of Research Université Paul Sabatier Toulouse III)
- Christine Chomienne (Former Director, Institut National du Cancer, France)
- Bartha Knoppers (Director of the Centre of Genomics and Policy, Faculty of Medicine, Department of Human Genetics, McGill University, Canada)
- Mark Lawler (Associate Pro-Vice-Chancellor and Professor of Cancer Genomics, Queen's University, Belfast, Northern Ireland)
- Mark McCarthy (Senior Director Human Genetics, Genentech, US)
- Aarno Palotie (Faculty member, Center for Human Genome Research, Massachusetts General Hospital; associate member at the Broad Institute of MIT and Harvard, US and Research Director of the Human Genomics Program at the Institute for Molecular Medicine Finland (FIMM) in Helsinki, Finland) - to be confirmed
- Augusto Rendon (Chief Bioinfomatician, Genomics England, UK)
- Ele Zeggini (Director, Institute of Translational Genomics, Munich, Germany)